Dr. D. Terrence Foster, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 240 Medical Blvd, Stockbridge, GA 30281 Phone: 678-284-4000 Fax: 678-284-6500 |
Dr. Paul King White, M.D. Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 165 N Park Trl Ste 100, Stockbridge, GA 30281 Phone: 770-506-1800 Fax: 770-389-4461 |
George Kevin Perdue, D.O. Physical Medicine & Rehabilitation - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 1240 Eagles Landing Pkwy, Suite 300, Stockbridge, GA 30281 Phone: 770-506-4350 |
Jeffrey Yoonsuk Lee, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 165 N Park Trl, Suite 100, Stockbridge, GA 30281 Phone: 770-506-1800 |
Paul Chang, MD Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1365 Rock Quarry Rd, Suite 301, Stockbridge, GA 30281 Phone: 770-771-6580 Fax: 770-771-6589 |
Dominic Shay Seymore, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 165 N Park Trl, Stockbridge, GA 30281 Phone: 770-506-1800 Fax: 770-506-4686 |
Sheree Edwards, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1240 Eagles Landing Pkwy Ste 300, Stockbridge, GA 30281 Phone: 770-506-4350 |
Christopher Andriano, D.O. Physical Medicine & Rehabilitation - Pain Medicine Medicare: Medicare Enrolled Practice Location: 1365 Rock Quarry Rd Ste 202, Stockbridge, GA 30281 Phone: 770-771-6580 |
News Archive
A new study from MIT reveals how cancer cells take some of their first steps away from their original tumor sites. This spread, known as metastasis, is responsible for 90 percent of cancer deaths.
Adam Hall, Ph.D., isn't kidding when he says the research he does is on a very small scale. But he is understating things more than just a little.
Various news outlets covered issues around cancer screening, diagnosis and treatment.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has signed a letter of agreement with Viropro, Inc., for the development of a biosimilar version of the monoclonal antibody drug rituximab (marketed by Genentech/Roche). Worldwide sales of rituximab in 2009 in all indications, including non-Hodgkin's lymphoma and chronic lymphocytic lymphoma, were approximately $5.6 billion.
A recent Mayo Clinic study found that people with chronic obstructive pulmonary disease (COPD) are about twice as likely to develop mild cognitive impairment (MCI) - and chances are that it will include memory loss. The study was recently published in Mayo Clinic Proceedings.
› Verified 3 days ago